Literature DB >> 24893093

Recurrence and mortality following severe cutaneous adverse reactions.

Yaron Finkelstein1, Erin M Macdonald2, Ping Li2, Janine R Hutson1, David N Juurlink3.   

Abstract

Mesh：

Year:  2014        PMID： 24893093     DOI： 10.1001/jama.2014.839

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  12 in total

Review 1.  The 9th International Congress on Cutaneous Adverse Drug Reactions at the 23rd World Congress of Dermatology in Vancouver, 2015.

Authors:  Roni P Dodiuk-Gad; Cristina Olteanu; Wen-Hung Chung; Neil H Shear
Journal:  Drug Saf       Date:  2016-03       Impact factor: 5.606

2.  A Retrospective Cohort Study of the Management and Outcomes of Children Hospitalized with Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis.

Authors:  James W Antoon; Jennifer L Goldman; Samir S Shah; Brian Lee
Journal:  J Allergy Clin Immunol Pract       Date:  2018-05-30

Review 3.  The 3 Cs of Antibiotic Allergy-Classification, Cross-Reactivity, and Collaboration.

Authors:  Jason A Trubiano; Cosby A Stone; M Lindsay Grayson; Karen Urbancic; Monica A Slavin; Karin A Thursky; Elizabeth J Phillips
Journal:  J Allergy Clin Immunol Pract       Date:  2017-08-23

4.  More than skin deep. Ten year follow-up of delayed cutaneous adverse drug reactions (CADR).

Authors:  Linda Velta Graudins; Jenny Ly; Jason Trubiano; Ar Kar Aung
Journal:  Br J Clin Pharmacol       Date:  2016-07-18       Impact factor: 4.335

5.  An effective strategy to prevent allopurinol-induced hypersensitivity by HLA typing.

Authors:  Jae-Woo Jung; Dong-Ki Kim; Heung-Woo Park; Kook-Hwan Oh; Kwon-Wook Joo; Yon-Su Kim; Curie Ahn; Kyung Wha Lee; Sang-Heon Cho; Kyung-Up Min; Hye-Ryun Kang
Journal:  Genet Med       Date:  2015-01-29       Impact factor: 8.822

6.  Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea.

Authors:  Min-Suk Yang; Jin Yong Lee; Jayeun Kim; Gun-Woo Kim; Byung-Keun Kim; Ju-Young Kim; Heung-Woo Park; Sang-Heon Cho; Kyung-Up Min; Hye-Ryun Kang
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

Review 7.  Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.

Authors:  Ran Wu; Yi-Ju Cheng; Li-Li Zhu; Lei Yu; Xue-Ke Zhao; Min Jia; Chang-Hui Wen; Xing-Zhen Long; Ting Tang; Ai-Juan He; Yi-Yan Zeng; Zun-Feng Ma; Zhi Zheng; Mu-Zi Ni; Gong-Jing Cai
Journal:  Oncotarget       Date:  2016-12-06

8.  Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).

Authors:  Virginia Velasco-Tirado; Montserrat Alonso-Sardón; Adriana Cosano-Quero; Ángela Romero-Alegría; Leire Sánchez-Los Arcos; Amparo López-Bernus; Javier Pardo-Lledías; Moncef Belhassen-García
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

Review 9.  A review of cutaneous hypersensitivity reactions in infants: From common to concerning.

Authors:  Kathryn A Arnold; Jingyun Gao; Sarah L Stein
Journal:  Pediatr Dermatol       Date:  2019-04-25       Impact factor: 1.588

10.  Stevens-Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database.

Authors:  Bernardo Sousa-Pinto; Luís Araújo; Alberto Freitas; Osvaldo Correia; Luís Delgado
Journal:  Clin Transl Allergy       Date:  2018-01-22       Impact factor: 5.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.